Autoimmune and inflammatory disorder biologicals will power biotech market growth through to 2010

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.12, Iss.3, 2006-04, pp. : 237-241

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cancer remains the dominant disease target for biotech through to 2010

By Pijpers Fleur Belsey Mark J

Journal of Commercial Biotechnology, Vol. 12, Iss. 4, 2006-07 ,pp. : 294-298

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Key financial trends that shape biotech business growth

By Pavlou Alex Belsey Mark

Journal of Commercial Biotechnology, Vol. 11, Iss. 2, 2005-01 ,pp. : 171-175

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

The DNA/RNA market to 2010

By Belsey Mark Pavlou Alex K

Journal of Commercial Biotechnology, Vol. 11, Iss. 3, 2005-04 ,pp. : 275-278

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Exploiting the business opportunities in biotech connections: The power of social networks

By McCarthy Ian P Pitt Leyland Campbell Colin Merwe Rian van der Salehi-Sangeri Esmail

Journal of Commercial Biotechnology, Vol. 13, Iss. 4, 2007-08 ,pp. : 245-257

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Growth of Indian biotech companies, in the context of the international biotechnology industry

By Palnitkar Utkarsh

Journal of Commercial Biotechnology, Vol. 11, Iss. 2, 2005-01 ,pp. : 146-154

Palgrave Macmillan Ltd

Access to resources Recommend Favorite